With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

New infrastructure strengthens Africa-based clinical trial logistics, reducing costs and accelerating timelines for ...

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

In the UK, wide‑ranging reforms coming into force on 28 April 2026 are designed to streamline approvals, embed a more ...